{"id":726,"date":"2022-11-25T10:45:42","date_gmt":"2022-11-25T09:45:42","guid":{"rendered":"https:\/\/dialab.umh.es\/?page_id=726"},"modified":"2026-01-22T13:52:42","modified_gmt":"2026-01-22T12:52:42","slug":"financiacion","status":"publish","type":"page","link":"https:\/\/dialab.umh.es\/es\/financiacion\/","title":{"rendered":"Financiaci\u00f3n"},"content":{"rendered":"

[et_pb_section fb_built=\u00bb1″ fullwidth=\u00bbon\u00bb _builder_version=\u00bb4.16″ custom_margin=\u00bb-180px||-180px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_fullwidth_header title=\u00bb\u00daLTIMOS 10 A\u00d1OS\u00bb subhead=\u00bbFinanciaci\u00f3n\u00bb header_fullscreen=\u00bbon\u00bb _builder_version=\u00bb4.17.4″ title_font=\u00bb|600|||||||\u00bb title_text_color=\u00bb#333399″ title_font_size=\u00bb20px\u00bb content_font=\u00bb||||||||\u00bb content_text_color=\u00bb#000000″ content_font_size=\u00bb20px\u00bb content_line_height=\u00bb1.8em\u00bb subhead_font=\u00bb|700|||||||\u00bb subhead_text_color=\u00bb#333399″ subhead_font_size=\u00bb53px\u00bb subhead_letter_spacing=\u00bb2px\u00bb subhead_line_height=\u00bb1.2em\u00bb background_enable_color=\u00bboff\u00bb use_background_color_gradient=\u00bbon\u00bb background_color_gradient_type=\u00bbcircular\u00bb background_color_gradient_direction_radial=\u00bbleft\u00bb background_color_gradient_stops=\u00bb#FFFFFF 36%|rgba(19,37,94,0) 100%\u00bb background_color_gradient_overlays_image=\u00bbon\u00bb background_color_gradient_start=\u00bb#FFFFFF\u00bb background_color_gradient_start_position=\u00bb36%\u00bb background_color_gradient_end=\u00bbrgba(19,37,94,0)\u00bb background_image=\u00bbhttps:\/\/dialab.umh.es\/files\/2022\/11\/funding.jpg\u00bb custom_button_one=\u00bbon\u00bb button_one_text_color=\u00bb#FFFFFF\u00bb button_one_bg_color=\u00bb#e00b00″ button_one_border_color=\u00bb#e00b00″ button_one_border_radius=\u00bb25px\u00bb button_one_font=\u00bb||||||||\u00bb button_one_use_icon=\u00bboff\u00bb button_one_custom_padding=\u00bb|35px||35px|false|true\u00bb background_layout=\u00bblight\u00bb subhead_font_size_tablet=\u00bb53px\u00bb subhead_font_size_phone=\u00bb40px\u00bb subhead_font_size_last_edited=\u00bbon|phone\u00bb button_one_border_color_last_edited=\u00bboff|desktop\u00bb global_colors_info=\u00bb{}\u00bb button_one_border_color__hover_enabled=\u00bbon|hover\u00bb button_one_border_color__hover=\u00bb#8c0000″ button_one_bg_color__hover_enabled=\u00bbon|hover\u00bb button_one_bg_color__hover=\u00bb#8c0000″ button_one_bg_enable_color__hover=\u00bbon\u00bb][\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb0px||0px|||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_4,1_4,1_4,1_4″ make_equal=\u00bbon\u00bb disabled_on=\u00bbon|on|on\u00bb _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb1307px\u00bb custom_css_main_element=\u00bbalign-items: center;\u00bb disabled=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_4″ _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/dialab.umh.es\/files\/2022\/10\/oberon.jpeg\u00bb alt=\u00bbLogo Goliath\u00bb title_text=\u00bboberon\u00bb url=\u00bbhttps:\/\/beatinggoliath.eu\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_4″ _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/dialab.umh.es\/files\/2022\/10\/MICINN-logo.png\u00bb alt=\u00bbLogo MICINN\u00bb title_text=\u00bbLogo MICINN\u00bb url=\u00bbhttps:\/\/www.ciencia.gob.es\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_4″ _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/dialab.umh.es\/files\/2022\/10\/logo-gva-proyecto-prometeo.png\u00bb alt=\u00bbLogo Prometeo GV\u00bb title_text=\u00bblogo-gva-proyecto-prometeo\u00bb url=\u00bbhttps:\/\/www.prometeu.es\/es\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb82%\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_4″ _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/dialab.umh.es\/files\/2022\/10\/logo-ciberdem.png\u00bb alt=\u00bbLogo Ciberdem\u00bb title_text=\u00bbLogo Ciberdem\u00bb url=\u00bbhttps:\/\/www.ciberdem.org\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.16″ global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ make_equal=\u00bbon\u00bb _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb1307px\u00bb custom_css_main_element=\u00bbalign-items: center;\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/dialab.umh.es\/files\/2022\/10\/MICINN-logo.png\u00bb alt=\u00bbLogo MICINN\u00bb title_text=\u00bbLogo MICINN\u00bb url=\u00bbhttps:\/\/www.ciencia.gob.es\/\u00bb url_new_window=\u00bbon\u00bb align=\u00bbcenter\u00bb _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/dialab.umh.es\/files\/2022\/10\/logo-gva-proyecto-prometeo.png\u00bb alt=\u00bbLogo Prometeo GV\u00bb title_text=\u00bblogo-gva-proyecto-prometeo\u00bb url=\u00bbhttps:\/\/isletcellsignal.umh.es\/prometeo-project\/\u00bb align=\u00bbcenter\u00bb _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb65%\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/dialab.umh.es\/files\/2026\/01\/ciberdem.png\u00bb alt=\u00bbLogo Ciberdem\u00bb title_text=\u00bbciberdem\u00bb url=\u00bbhttps:\/\/www.ciberdem.org\/\u00bb url_new_window=\u00bbon\u00bb align=\u00bbcenter\u00bb _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ use_custom_gutter=\u00bbon\u00bb gutter_width=\u00bb2″ make_equal=\u00bbon\u00bb _builder_version=\u00bb4.16″ max_width=\u00bb100%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbChallenges for maternal diabetes prevention after gestational diabetes: deciphering the molecular and functional endocrine pancreas remodelling during pregnancy and postpartum.\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb background_layout=\u00bbdark\u00bb custom_margin=\u00bb|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb] <\/p>\n

Proyectos I+D+I 2023 – Modalidades \u00abRetos Investigaci\u00f3n\u00bb y \u00abGeneraci\u00f3n de Conocimiento\u00bb PID2023 – AEI\/MCI. AGENCIA ESTATAL DE INVESTIGACION.<\/p>\n

REF: PID2023-146795OB-I00 Desde: 01\/09\/2024 hasta: 31\/12\/2028<\/strong><\/p>\n

IP: PALOMA ALONSO-MAGDALENA e IVAN QUESADA MOLL[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbUnderstanding the role of endocrine disruptors in the transition from pregnancy to postpartum: an opportunity to prevent maternal diabetes.\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb custom_margin=\u00bb|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb] <\/p>\n

Programa de Excelencia PROMETEO, Generalitat Valenciana. CIPROM\/2023\/27 Duraci\u00f3n, desde: 01\/09\/2024 hasta: 31\/08\/2028<\/p>\n

IP: PALOMA ALONSO-MAGDALENA e ANGEL NADAL NAVAJAS<\/p>\n

<\/b>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbTowards understanding the effects of bile acids on the endocrine pancreas: from health to obesity and double burden of malnutrition.\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb background_layout=\u00bbdark\u00bb custom_margin=\u00bb|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb] <\/p>\n

PROGRAMA SPRINT PARA PROYECTOS INTERNACIONALES DE INVESTIGACI\u00d3N (SPRINT-UMH-FAPESP). Universidad Miguel Hern\u00e1ndez de Elche- FAPESP Sao Paulo, Brazil.
\nREF: SPRINTUMH2024_1 Desde: 21\/10\/2024 hasta: 31\/10\/2025<\/strong><\/p>\n

IP: IVAN QUESADA MOLL[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ use_custom_gutter=\u00bbon\u00bb gutter_width=\u00bb2″ make_equal=\u00bbon\u00bb _builder_version=\u00bb4.16″ max_width=\u00bb100%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbPapel de la se\u00f1alizaci\u00f3n mediada por TGFbeta en las adaptaciones metab\u00f3licas maternas durante el embarazo: implicaciones para el desarrollo de la diabetes mellitus gestacional. \u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb background_layout=\u00bbdark\u00bb custom_margin=\u00bb|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

 <\/p>\n

Proyectos I+D+I 2020 – Modalidades \u00abRetos Investigaci\u00f3n\u00bb y \u00abGeneraci\u00f3n de Conocimiento\u00bb PID2020 – AEI\/MCI. AGENCIA ESTATAL DE INVESTIGACION.
REF: PID2020-113112RB-I00 01\/09\/2021- 31\/08\/2024<\/strong><\/p>\n

PI: PALOMA ALONSO-MAGDALENA<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbLa v\u00eda de se\u00f1alizaci\u00f3n mediada por TGF\u03b2 y su relaci\u00f3n con la etiolog\u00eda de la diabetes mellitus gestacional: explorando nuevos biomarcadores de diagn\u00f3stico (BIODIAGES).\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb custom_margin=\u00bb|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

 <\/p>\n

Acciones preparatorias para la exploraci\u00f3n y formulaci\u00f3n de futuros proyectos de investigaci\u00f3n\/innovaci\u00f3n 2022. Subprograma ILISABIO. 2022-2023<\/p>\n

PI: PALOMA ALONSO-MAGDALENA and RUB\u00c9N BETORET GUSTEMS<\/p>\n

 <\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbAbordando el papel del p\u00e1ncreas endocrino en el envejecimiento: nuevas estrategias y perspectivas.\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb background_layout=\u00bbdark\u00bb custom_margin=\u00bb|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

 <\/p>\n

PROGRAMA DE AYUDAS PARA LA INVESTIGACI\u00d3N DEL ENVEJECIMIENTO DE LA FUNDACI\u00d3N ICAR, Convocatoria 2023. Fundaci\u00f3n Centro Internacional para la Investigaci\u00f3n del Envejecimiento (ICAR) Desde 01-01-2023 hasta: 31-12-2023
<\/strong><\/p>\n

IP: SERGI SORIANO \u00daBEDA e IVAN QUESADA MOLL<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ use_custom_gutter=\u00bbon\u00bb gutter_width=\u00bb2″ make_equal=\u00bbon\u00bb _builder_version=\u00bb4.16″ max_width=\u00bb100%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbAn integrative strategy of testing systems for identification of EDs related to metabolic disorders\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb background_layout=\u00bbdark\u00bb custom_margin=\u00bb|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb] <\/p>\n

EUROPEAN COMMISSION, Horizon 2020 – Research and Innovation Framework Programme.<\/p>\n

01\/01\/2019-31\/12\/2023<\/strong><\/p>\n

PI: PALOMA ALONSO-MAGDALENA[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbRegulaci\u00f3n de la viabilidad y la funci\u00f3n de las c\u00e9lulas \u03b2 y \u03b1 pancre\u00e1ticas por los receptores de estr\u00f3genos ER\u03b2 y GPER: papel en la terapia de la diabetes mellitus.\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb custom_margin=\u00bb||0px|||\u00bb custom_padding=\u00bb||0px|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

 <\/p>\n

Programa de Excelencia PROMETEO, Generalitat Valenciana. 01\/01\/2020- 31\/12\/2023<\/strong><\/p>\n

PI: ANGEL NADAL NAVAJAS<\/p>\n

 <\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbFunci\u00f3n de la c\u00e9lula alfa pancre\u00e1tica durante el envejecimiento: implicaciones en la homeostasis de la glucosa.\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb background_layout=\u00bbdark\u00bb custom_margin=\u00bb||-1px|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

 <\/p>\n

MINISTERIO DE ECONOM\u00edA (PLAN NACIONAL DE I+D+I).<\/p>\n

REF: BFU2016-77125-R 30\/12\/2016-31\/12\/2020<\/strong><\/p>\n

PI: IVAN QUESADA MOLL<\/p>\n

 <\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ use_custom_gutter=\u00bbon\u00bb gutter_width=\u00bb2″ make_equal=\u00bbon\u00bb _builder_version=\u00bb4.16″ max_width=\u00bb100%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbEfectos del ambiente estrog\u00e9nico materno durante el per\u00edodo gestacional en el desarrollo y funci\u00f3n del p\u00e1ncreas endocrino fetal. \u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb custom_margin=\u00bb||-3px|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

 <\/p>\n

Sociedad Espa\u00f1ola de Diabetes (2015-2016).<\/p>\n

PI: PALOMA ALONSO-MAGDALENA.<\/p>\n

 <\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbAlteraciones en la funci\u00f3n de la c\u00e9lula alfa pancre\u00e1tica y en la secreci\u00f3n de glucag\u00f3n: contribuci\u00f3n a la hiperglicemia y a la diabetes tipo 1 Y 2.\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb background_layout=\u00bbdark\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

 <\/p>\n

MINISTERIO DE ECONOM\u00edA (PLAN NACIONAL DE I+D+I).<\/p>\n

REF: BFU2013-42789 01\/01\/2014-31\/12\/2016<\/strong><\/p>\n

PI: IVAN QUESADA MOLL<\/p>\n

 <\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbExposure to endocrine disruptor chemicals during pregnancy: a possible mechanism involved in the premature ageing of maternal pancreatic b-cell.\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb background_layout=\u00bbdark\u00bb custom_margin=\u00bb||-2px|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

 <\/p>\n

European Foundation for the Study of Diabetes\/Lilly Research Fellowship Programme, 2013-2015.<\/p>\n

PI: PALOMA ALONSO-MAGDALENA.<\/p>\n

 <\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ use_custom_gutter=\u00bbon\u00bb gutter_width=\u00bb2″ make_equal=\u00bbon\u00bb _builder_version=\u00bb4.17.4″ max_width=\u00bb100%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbFunctional and structural adaptations in the alpha cell and changes in glucagon action during obesity.\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb custom_margin=\u00bb|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

 <\/p>\n

EUROPEAN FOUNDATION FOR THE STUDY DIABETES (EFSD); EFSD\/Boehringer-Ingelheim Basic Programme on the Regulation of Secretion and Function of Non-Insulin Peptides from the Endocrine Pancreas. 01\/10\/2012-30\/09\/2014<\/strong>
<\/b><\/p>\n

PI: IVAN QUESADA MOLL<\/p>\n

 <\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb box_shadow_style=\u00bbpreset1″ global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_blurb title=\u00bbCaracterizaci\u00f3n del efecto insulinotr\u00f3pico r\u00e1pido de agonistas espec\u00edficos del receptor de estr\u00f3genos beta: implicaciones en el tratamiento de la diabetes.\u00bb content_max_width=\u00bb100%\u00bb _builder_version=\u00bb4.17.4″ header_font=\u00bbPT Sans|700|||||||\u00bb header_text_color=\u00bb#000000″ header_line_height=\u00bb25px\u00bb body_font=\u00bbPT Sans||||||||\u00bb body_text_color=\u00bb#000000″ body_font_size=\u00bb16px\u00bb body_line_height=\u00bb1.8em\u00bb text_orientation=\u00bbcenter\u00bb background_layout=\u00bbdark\u00bb custom_margin=\u00bb|||\u00bb custom_padding=\u00bb|||\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_intensity_slide=\u00bb10%\u00bb animation=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

 <\/p>\n

Programa de Excelencia PROMETEO, Generalitat Valenciana. 01\/01\/2011-31\/12\/2014.<\/strong><\/p>\n

PI: ANGEL NADAL<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.17.4″ background_color=\u00bbrgba(255,255,255,0.39)\u00bb custom_padding=\u00bb30px|30px|30px|30px\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

  Proyectos I+D+I 2023 – Modalidades \u00abRetos Investigaci\u00f3n\u00bb y \u00abGeneraci\u00f3n de Conocimiento\u00bb PID2023 – AEI\/MCI. AGENCIA ESTATAL DE INVESTIGACION. REF: PID2023-146795OB-I00 Desde: 01\/09\/2024 hasta: 31\/12\/2028 IP: PALOMA ALONSO-MAGDALENA e IVAN QUESADA MOLL  Programa de Excelencia PROMETEO, Generalitat Valenciana. CIPROM\/2023\/27 Duraci\u00f3n, desde: 01\/09\/2024 hasta: 31\/08\/2028 IP: PALOMA ALONSO-MAGDALENA e ANGEL NADAL NAVAJAS   PROGRAMA SPRINT PARA […]<\/p>\n","protected":false},"author":23459,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"

[et_pb_section fb_built=\"1\" fullwidth=\"on\" _builder_version=\"4.16\" custom_margin=\"-180px||-180px||true|false\" global_colors_info=\"{}\"][et_pb_fullwidth_header title=\"LAST 10 YEARS\" subhead=\"Funding\" header_fullscreen=\"on\" _builder_version=\"4.17.4\" title_font=\"|600|||||||\" title_text_color=\"#333399\" title_font_size=\"20px\" content_font=\"||||||||\" content_text_color=\"#000000\" content_font_size=\"20px\" content_line_height=\"1.8em\" subhead_font=\"|700|||||||\" subhead_text_color=\"#333399\" subhead_font_size=\"53px\" subhead_letter_spacing=\"2px\" subhead_line_height=\"1.2em\" background_enable_color=\"off\" use_background_color_gradient=\"on\" background_color_gradient_type=\"circular\" background_color_gradient_direction_radial=\"left\" background_color_gradient_stops=\"#FFFFFF 36%|rgba(19,37,94,0) 100%\" background_color_gradient_overlays_image=\"on\" background_color_gradient_start=\"#FFFFFF\" background_color_gradient_start_position=\"36%\" background_color_gradient_end=\"rgba(19,37,94,0)\" background_image=\"https:\/\/dialab.umh.es\/files\/2022\/11\/funding.jpg\" custom_button_one=\"on\" button_one_text_color=\"#FFFFFF\" button_one_bg_color=\"#e00b00\" button_one_border_color=\"#e00b00\" button_one_border_radius=\"25px\" button_one_font=\"||||||||\" button_one_use_icon=\"off\" button_one_custom_padding=\"|35px||35px|false|true\" background_layout=\"light\" button_one_border_color_last_edited=\"off|desktop\" global_colors_info=\"{}\" button_one_border_color__hover_enabled=\"on|hover\" button_one_border_color__hover=\"#8c0000\" button_one_bg_color__hover_enabled=\"on|hover\" button_one_bg_color__hover=\"#8c0000\" button_one_bg_enable_color__hover=\"on\"][\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=\"1\" _builder_version=\"4.17.4\" _module_preset=\"default\" custom_padding=\"0px||0px|||\" global_colors_info=\"{}\"][et_pb_row column_structure=\"1_4,1_4,1_4,1_4\" make_equal=\"on\" _builder_version=\"4.17.4\" _module_preset=\"default\" max_width=\"1307px\" custom_css_main_element=\"align-items: center;\" global_colors_info=\"{}\"][et_pb_column type=\"1_4\" _builder_version=\"4.17.4\" _module_preset=\"default\" global_colors_info=\"{}\"][et_pb_image src=\"https:\/\/dialab.umh.es\/files\/2022\/10\/oberon.jpeg\" alt=\"Logo Goliath\" title_text=\"oberon\" url=\"https:\/\/beatinggoliath.eu\/\" url_new_window=\"on\" _builder_version=\"4.17.4\" _module_preset=\"default\" global_colors_info=\"{}\"][\/et_pb_image][\/et_pb_column][et_pb_column type=\"1_4\" _builder_version=\"4.17.4\" _module_preset=\"default\" global_colors_info=\"{}\"][et_pb_image src=\"https:\/\/dialab.umh.es\/files\/2022\/10\/MICINN-logo.png\" alt=\"Logo MICINN\" title_text=\"Logo MICINN\" url=\"https:\/\/www.ciencia.gob.es\/\" url_new_window=\"on\" _builder_version=\"4.17.4\" _module_preset=\"default\" global_colors_info=\"{}\"][\/et_pb_image][\/et_pb_column][et_pb_column type=\"1_4\" _builder_version=\"4.17.4\" _module_preset=\"default\" global_colors_info=\"{}\"][et_pb_image src=\"https:\/\/dialab.umh.es\/files\/2022\/10\/logo-gva-proyecto-prometeo.png\" alt=\"Logo Prometeo GV\" title_text=\"logo-gva-proyecto-prometeo\" url=\"https:\/\/www.prometeu.es\/es\/\" url_new_window=\"on\" _builder_version=\"4.17.4\" _module_preset=\"default\" max_width=\"82%\" global_colors_info=\"{}\"][\/et_pb_image][\/et_pb_column][et_pb_column type=\"1_4\" _builder_version=\"4.17.4\" _module_preset=\"default\" global_colors_info=\"{}\"][et_pb_image src=\"https:\/\/dialab.umh.es\/files\/2022\/10\/logo-ciberdem.png\" alt=\"Logo Ciberdem\" title_text=\"Logo Ciberdem\" url=\"https:\/\/www.ciberdem.org\/\" url_new_window=\"on\" _builder_version=\"4.17.4\" _module_preset=\"default\" global_colors_info=\"{}\"][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\"1\" _builder_version=\"4.16\" global_colors_info=\"{}\"][et_pb_row column_structure=\"1_3,1_3,1_3\" use_custom_gutter=\"on\" gutter_width=\"2\" make_equal=\"on\" _builder_version=\"4.16\" max_width=\"100%\" global_colors_info=\"{}\"][et_pb_column type=\"1_3\" _builder_version=\"4.16\" background_color=\"rgba(255,255,255,0.39)\" custom_padding=\"30px|30px|30px|30px\" box_shadow_style=\"preset1\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][et_pb_blurb title=\"The role of TGF signaling in maternal metabolic adaptations during pregnancy: implications for the development of gestational diabetes mellitus.\" content_max_width=\"100%\" _builder_version=\"4.17.4\" header_font=\"PT Sans|700|||||||\" header_text_color=\"#000000\" header_line_height=\"25px\" body_font=\"PT Sans||||||||\" body_text_color=\"#000000\" body_font_size=\"16px\" body_line_height=\"1.8em\" text_orientation=\"center\" background_layout=\"dark\" custom_margin=\"|||\" custom_padding=\"|||\" animation_style=\"slide\" animation_direction=\"bottom\" animation_intensity_slide=\"10%\" animation=\"off\" global_colors_info=\"{}\"]<\/p>

\u00a0<\/p>

Proyectos I+D+I 2020 - Modalidades \"Retos Investigaci\u00f3n\" y \"Generaci\u00f3n de Conocimiento\" PID2020 - AEI\/MCI. AGENCIA ESTATAL DE INVESTIGACION.
REF: PID2020-113112RB-I00 01\/09\/2021- 31\/08\/2024<\/strong><\/p>

PI: PALOMA ALONSO-MAGDALENA<\/p>

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\"1_3\" _builder_version=\"4.16\" background_color=\"rgba(255,255,255,0.39)\" custom_padding=\"30px|30px|30px|30px\" box_shadow_style=\"preset1\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][et_pb_blurb title=\"La v\u00eda de se\u00f1alizaci\u00f3n mediada por TGF\u03b2 y su relaci\u00f3n con la etiolog\u00eda de la diabetes mellitus gestacional: explorando nuevos biomarcadores de diagn\u00f3stico (BIODIAGES).\" content_max_width=\"100%\" _builder_version=\"4.17.4\" header_font=\"PT Sans|700|||||||\" header_text_color=\"#000000\" header_line_height=\"25px\" body_font=\"PT Sans||||||||\" body_text_color=\"#000000\" body_font_size=\"16px\" body_line_height=\"1.8em\" text_orientation=\"center\" custom_margin=\"|||\" custom_padding=\"|||\" animation_style=\"slide\" animation_direction=\"bottom\" animation_intensity_slide=\"10%\" animation=\"off\" global_colors_info=\"{}\"]<\/p>

Acciones preparatorias para la exploraci\u00f3n y formulaci\u00f3n de futuros proyectos de investigaci\u00f3n\/innovaci\u00f3n 2022. Subprograma ILISABIO. 2022-2023<\/p>

PI: PALOMA ALONSO-MAGDALENA and RUB\u00c9N BETORET GUSTEMS<\/p>

\u00a0<\/p>

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\"1_3\" _builder_version=\"4.16\" background_color=\"rgba(255,255,255,0.39)\" custom_padding=\"30px|30px|30px|30px\" box_shadow_style=\"preset1\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][et_pb_blurb title=\"An integrative strategy of testing systems for identification of EDs related to metabolic disorders\" content_max_width=\"100%\" _builder_version=\"4.17.4\" header_font=\"PT Sans|700|||||||\" header_text_color=\"#000000\" header_line_height=\"25px\" body_font=\"PT Sans||||||||\" body_text_color=\"#000000\" body_font_size=\"16px\" body_line_height=\"1.8em\" text_orientation=\"center\" background_layout=\"dark\" custom_margin=\"|||\" custom_padding=\"|||\" animation_style=\"slide\" animation_direction=\"bottom\" animation_intensity_slide=\"10%\" animation=\"off\" global_colors_info=\"{}\"]<\/p>

\u00a0<\/p>

EUROPEAN COMMISSION, Horizon 2020 - Research and Innovation Framework Programme.<\/p>

01\/01\/2019-31\/12\/2023<\/strong><\/p>

PI: PALOMA ALONSO-MAGDALENA<\/p>

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\"1_3,1_3,1_3\" use_custom_gutter=\"on\" gutter_width=\"2\" make_equal=\"on\" _builder_version=\"4.16\" max_width=\"100%\" global_colors_info=\"{}\"][et_pb_column type=\"1_3\" _builder_version=\"4.16\" background_color=\"rgba(255,255,255,0.39)\" custom_padding=\"30px|30px|30px|30px\" box_shadow_style=\"preset1\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][et_pb_blurb title=\"Regulation of pancreatic \u03b2- and \u03b1-cell viability and function by estrogen receptors ER\u03b2 and GPER: role in diabetes mellitus therapy\" content_max_width=\"100%\" _builder_version=\"4.17.4\" header_font=\"PT Sans|700|||||||\" header_text_color=\"#000000\" header_line_height=\"25px\" body_font=\"PT Sans||||||||\" body_text_color=\"#000000\" body_font_size=\"16px\" body_line_height=\"1.8em\" text_orientation=\"center\" custom_margin=\"|||\" custom_padding=\"|||\" animation_style=\"slide\" animation_direction=\"bottom\" animation_intensity_slide=\"10%\" animation=\"off\" global_colors_info=\"{}\"]<\/p>

\u00a0<\/p>

\u00a0<\/p>

Programa de Excelencia PROMETEO, Generalitat Valenciana. 01\/01\/2020- 31\/12\/2023<\/strong><\/p>

PI: ANGEL NADAL NAVAJAS<\/p>

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\"1_3\" _builder_version=\"4.16\" background_color=\"rgba(255,255,255,0.39)\" custom_padding=\"30px|30px|30px|30px\" box_shadow_style=\"preset1\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][et_pb_blurb title=\"Pancreatic alpha cell function during aging: implications for glucose homeostasis.\" content_max_width=\"100%\" _builder_version=\"4.17.4\" header_font=\"PT Sans|700|||||||\" header_text_color=\"#000000\" header_line_height=\"25px\" body_font=\"PT Sans||||||||\" body_text_color=\"#000000\" body_font_size=\"16px\" body_line_height=\"1.8em\" text_orientation=\"center\" background_layout=\"dark\" custom_margin=\"|||\" custom_padding=\"|||\" animation_style=\"slide\" animation_direction=\"bottom\" animation_intensity_slide=\"10%\" animation=\"off\" global_colors_info=\"{}\"]<\/p>

\u00a0<\/p>

\u00a0<\/p>

\u00a0<\/p>

MINISTERIO DE ECONOM\u00edA (PLAN NACIONAL DE I+D+I).<\/p>

REF: BFU2016-77125-R 30\/12\/2016-31\/12\/2020<\/strong><\/p>

PI: IVAN QUESADA MOLL<\/p>

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\"1_3\" _builder_version=\"4.16\" background_color=\"rgba(255,255,255,0.39)\" custom_padding=\"30px|30px|30px|30px\" box_shadow_style=\"preset1\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][et_pb_blurb title=\"Efectos del ambiente estrog\u00e9nico materno durante el per\u00edodo gestacional en el desarrollo y funci\u00f3n del p\u00e1ncreas endocrino fetal. \" content_max_width=\"100%\" _builder_version=\"4.17.4\" header_font=\"PT Sans|700|||||||\" header_text_color=\"#000000\" header_line_height=\"25px\" body_font=\"PT Sans||||||||\" body_text_color=\"#000000\" body_font_size=\"16px\" body_line_height=\"1.8em\" text_orientation=\"center\" custom_margin=\"|||\" custom_padding=\"|||\" animation_style=\"slide\" animation_direction=\"bottom\" animation_intensity_slide=\"10%\" animation=\"off\" global_colors_info=\"{}\"]<\/p>

\u00a0<\/p>

\u00a0<\/p>

Sociedad Espa\u00f1ola de Diabetes (2015-2016).<\/p>

PI: PALOMA ALONSO-MAGDALENA.<\/p>

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\"1_3,1_3,1_3\" use_custom_gutter=\"on\" gutter_width=\"2\" make_equal=\"on\" _builder_version=\"4.17.4\" max_width=\"100%\" global_colors_info=\"{}\"][et_pb_column type=\"1_3\" _builder_version=\"4.16\" background_color=\"rgba(255,255,255,0.39)\" custom_padding=\"30px|30px|30px|30px\" box_shadow_style=\"preset1\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][et_pb_blurb title=\"Alteraciones en la funci\u00f3n de la c\u00e9lula alfa pancre\u00e1tica y en la secreci\u00f3n de glucag\u00f3n: contribuci\u00f3n a la hiperglicemia y a la diabetes tipo 1 Y 2.\" content_max_width=\"100%\" _builder_version=\"4.17.4\" header_font=\"PT Sans|700|||||||\" header_text_color=\"#000000\" header_line_height=\"25px\" body_font=\"PT Sans||||||||\" body_text_color=\"#000000\" body_font_size=\"16px\" body_line_height=\"1.8em\" text_orientation=\"center\" background_layout=\"dark\" custom_margin=\"|||\" custom_padding=\"|||\" animation_style=\"slide\" animation_direction=\"bottom\" animation_intensity_slide=\"10%\" animation=\"off\" global_colors_info=\"{}\"]<\/p>

\u00a0<\/p>

MINISTERIO DE ECONOM\u00edA (PLAN NACIONAL DE I+D+I).<\/p>

REF: BFU2013-42789 01\/01\/2014-31\/12\/2016<\/strong><\/p>

PI: IVAN QUESADA MOLL<\/p>

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\"1_3\" _builder_version=\"4.16\" background_color=\"rgba(255,255,255,0.39)\" custom_padding=\"30px|30px|30px|30px\" box_shadow_style=\"preset1\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][et_pb_blurb title=\"Exposure to endocrine disruptor chemicals during pregnancy: a possible mechanism involved in the premature ageing of maternal pancreatic b-cell.\" content_max_width=\"100%\" _builder_version=\"4.17.4\" header_font=\"PT Sans|700|||||||\" header_text_color=\"#000000\" header_line_height=\"25px\" body_font=\"PT Sans||||||||\" body_text_color=\"#000000\" body_font_size=\"16px\" body_line_height=\"1.8em\" text_orientation=\"center\" background_layout=\"dark\" custom_margin=\"|||\" custom_padding=\"|||\" animation_style=\"slide\" animation_direction=\"bottom\" animation_intensity_slide=\"10%\" animation=\"off\" global_colors_info=\"{}\"]<\/p>

\u00a0<\/p>

European Foundation for the Study of Diabetes\/Lilly Research Fellowship Programme, 2013-2015.<\/p>

PI: PALOMA ALONSO-MAGDALENA.<\/p>

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\"1_3\" _builder_version=\"4.16\" background_color=\"rgba(255,255,255,0.39)\" custom_padding=\"30px|30px|30px|30px\" box_shadow_style=\"preset1\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][et_pb_blurb title=\"Functional and structural adaptations in the alpha cell and changes in glucagon action during obesity.\" content_max_width=\"100%\" _builder_version=\"4.17.4\" header_font=\"PT Sans|700|||||||\" header_text_color=\"#000000\" header_line_height=\"25px\" body_font=\"PT Sans||||||||\" body_text_color=\"#000000\" body_font_size=\"16px\" body_line_height=\"1.8em\" text_orientation=\"center\" custom_margin=\"|||\" custom_padding=\"|||\" animation_style=\"slide\" animation_direction=\"bottom\" animation_intensity_slide=\"10%\" animation=\"off\" global_colors_info=\"{}\"]<\/p>

\u00a0<\/p>

EUROPEAN FOUNDATION FOR THE STUDY DIABETES (EFSD); EFSD\/Boehringer-Ingelheim Basic Programme on the Regulation of Secretion and Function of Non-Insulin Peptides from the Endocrine Pancreas. 01\/10\/2012-30\/09\/2014<\/strong>
<\/b><\/p>

PI: IVAN QUESADA MOLL<\/p>

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\"1_3,1_3,1_3\" use_custom_gutter=\"on\" gutter_width=\"2\" make_equal=\"on\" _builder_version=\"4.17.4\" max_width=\"100%\" global_colors_info=\"{}\"][et_pb_column type=\"1_3\" _builder_version=\"4.16\" background_color=\"rgba(255,255,255,0.39)\" custom_padding=\"30px|30px|30px|30px\" box_shadow_style=\"preset1\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][et_pb_blurb title=\"Characterization of the rapid insulinotropic effect of specific estrogen receptor beta agonists: implications for the treatment of diabetes. \" content_max_width=\"100%\" _builder_version=\"4.17.4\" header_font=\"PT Sans|700|||||||\" header_text_color=\"#000000\" header_line_height=\"25px\" body_font=\"PT Sans||||||||\" body_text_color=\"#000000\" body_font_size=\"16px\" body_line_height=\"1.8em\" text_orientation=\"center\" background_layout=\"dark\" custom_margin=\"|||\" custom_padding=\"|||\" animation_style=\"slide\" animation_direction=\"bottom\" animation_intensity_slide=\"10%\" animation=\"off\" global_colors_info=\"{}\"]<\/p>

\u00a0<\/p>

Programa de Excelencia PROMETEO, Generalitat Valenciana. 01\/01\/2011-31\/12\/2014.<\/strong><\/p>

PI: ANGEL NADAL<\/p>

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\"1_3\" _builder_version=\"4.17.4\" background_color=\"rgba(255,255,255,0.39)\" custom_padding=\"30px|30px|30px|30px\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][\/et_pb_column][et_pb_column type=\"1_3\" _builder_version=\"4.17.4\" background_enable_color=\"off\" custom_padding=\"30px|30px|30px|30px\" global_colors_info=\"{}\" custom_padding__hover=\"|||\"][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","_et_gb_content_width":"","_links_to":"","_links_to_target":""},"_links":{"self":[{"href":"https:\/\/dialab.umh.es\/es\/wp-json\/wp\/v2\/pages\/726"}],"collection":[{"href":"https:\/\/dialab.umh.es\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dialab.umh.es\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dialab.umh.es\/es\/wp-json\/wp\/v2\/users\/23459"}],"replies":[{"embeddable":true,"href":"https:\/\/dialab.umh.es\/es\/wp-json\/wp\/v2\/comments?post=726"}],"version-history":[{"count":0,"href":"https:\/\/dialab.umh.es\/es\/wp-json\/wp\/v2\/pages\/726\/revisions"}],"wp:attachment":[{"href":"https:\/\/dialab.umh.es\/es\/wp-json\/wp\/v2\/media?parent=726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}